id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA-2020-0017-0005,DEA,DEA-2020-0017,Schedules of Controlled Substances: Placement of Isotonitazene in Schedule I,Rule,,2021-11-04T04:00:00Z,2021,11,2021-11-04T04:00:00Z,,2021-11-04T12:13:37Z,2021-23848,0,0,0900006484e17dd9
DEA-2020-0017-0004,DEA,DEA-2020-0017,Three Factor Analysis for Temporary Control of Isotonitazene (DEA631) 07.21.20,Supporting & Related Material,,2020-08-21T04:00:00Z,2020,8,,,2020-08-21T07:35:45Z,,0,0,0900006484815d4e
DEA-2020-0017-0003,DEA,DEA-2020-0017,Schedules of Controlled Substances: Temporary Placement of Isotonitazene in Schedule I,Rule,,2020-08-20T04:00:00Z,2020,8,2020-08-20T04:00:00Z,,2020-08-20T20:50:10Z,2020-17951,0,0,0900006484813e61
DEA-2020-0017-0002,DEA,DEA-2020-0017,Three Factor Analysis for Temporary Control of Isotonitazene (DEA631) CLEAN 05052020 (1),Supporting & Related Material,,2020-06-19T00:00:00Z,2020,6,,,2020-08-21T07:31:31Z,,0,1,09000064846fae6c
DEA-2020-0017-0001,DEA,DEA-2020-0017,Schedules of Controlled Substances: Temporary Placement of Isotonitazene in Schedule I,Proposed Rule,,2020-06-18T04:00:00Z,2020,6,2020-06-18T04:00:00Z,,2020-06-19T13:24:57Z,2020-12304,0,0,09000064846f8a81